ISOKET 0.1 %w/v Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

isoket 0.1 %w/v concentrate for soln for inf

ucb pharma limited - isosorbide dinitrate - concentrate for soln for inf - 0.1 %w/v

Ethinylestradiol 1mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ethinylestradiol 1mg tablets

ucb pharma ltd - ethinylestradiol - oral tablet - 1mg

Elantan 40 tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elantan 40 tablets

ucb pharma ltd - isosorbide mononitrate - oral tablet - 40mg

Elantan 20 tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elantan 20 tablets

ucb pharma ltd - isosorbide mononitrate - oral tablet - 20mg

KEPPRA levetiracetam 750mg tablet Australia - English - Department of Health (Therapeutic Goods Administration)

keppra levetiracetam 750mg tablet

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 750 mg - tablet, film coated - excipient ingredients: macrogol 6000; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Cetirizine 10mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cetirizine 10mg tablets

dexcel-pharma ltd - cetirizine hydrochloride - oral tablet - 10mg

BRIVIACT 10 MG FILM COATED TABLETS Israel - English - Ministry of Health

briviact 10 mg film coated tablets

neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 10 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

BRIVIACT 100 MG FILM COATED TABLETS Israel - English - Ministry of Health

briviact 100 mg film coated tablets

neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 100 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

BRIVIACT 25 MG FILM COATED TABLETS Israel - English - Ministry of Health

briviact 25 mg film coated tablets

neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 25 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.mg/kg/day.

BRIVIACT 50 MG FILM COATED TABLETS Israel - English - Ministry of Health

briviact 50 mg film coated tablets

neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 50 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.